D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 95 Citations 31,088 427 World Ranking 6164 National Ranking 3387

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Surgery

Douglas A. Jabs mostly deals with Surgery, Eye disease, Internal medicine, Uveitis and Retrospective cohort study. The Surgery study combines topics in areas such as Retinitis, Cohort study and Disease. Douglas A. Jabs combines subjects such as Retinopathy and Acquired immunodeficiency syndrome with his study of Retinitis.

The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Scleritis, Cytomegalovirus retinitis and Immunology. The subject of his Uveitis research is within the realm of Ophthalmology. His research in the fields of Visual acuity, Macular edema and Epiretinal membrane overlaps with other disciplines such as Visual impairment.

His most cited work include:

  • Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. (2370 citations)
  • Paraneoplastic Pemphigus: An Autoimmune Mucocutaneous Disease Associated with Neoplasia (766 citations)
  • Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel (703 citations)

What are the main themes of his work throughout his whole career to date?

Douglas A. Jabs spends much of his time researching Surgery, Cytomegalovirus retinitis, Retinitis, Ophthalmology and Uveitis. Douglas A. Jabs works mostly in the field of Surgery, limiting it down to concerns involving Internal medicine and, occasionally, Gastroenterology. His Cytomegalovirus retinitis research includes elements of Acquired immunodeficiency syndrome and Pediatrics.

His Retinitis study combines topics from a wide range of disciplines, such as Prospective cohort study, Betaherpesvirinae and Viral load. His Uveitis research is multidisciplinary, incorporating elements of Dermatology, Fluocinolone acetonide and Disease. His biological study spans a wide range of topics, including Immunopathology and Pathology.

He most often published in these fields:

  • Surgery (46.38%)
  • Cytomegalovirus retinitis (40.58%)
  • Retinitis (41.49%)

What were the highlights of his more recent work (between 2017-2021)?

  • Confidence interval (15.94%)
  • Training set (8.33%)
  • Uveitis (37.14%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Confidence interval, Training set, Uveitis, Ophthalmology and Internal medicine. His research in Training set intersects with topics in Anterior uveitis, Intermediate uveitis, Fluorescein angiography and Pediatrics. His Uveitis research is multidisciplinary, incorporating perspectives in Choroiditis, Optometry, Visual acuity and Disease.

His work on Retinal as part of general Ophthalmology study is frequently connected to In patient, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. His Internal medicine study frequently draws connections to adjacent fields such as Acquired immunodeficiency syndrome. His work deals with themes such as Longitudinal study and Cytomegalovirus retinitis, which intersect with Prospective cohort study.

Between 2017 and 2021, his most popular works were:

  • Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal Corticosteroids for Uveitic Macular Edema (POINT) Trial (42 citations)
  • Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal Corticosteroids for Uveitic Macular Edema (POINT) Trial (42 citations)
  • Immunosuppression for the Uveitides. (36 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Cancer

The scientist’s investigation covers issues in Uveitis, Internal medicine, Incidence, Proportional hazards model and Prospective cohort study. His Uveitis research is included under the broader classification of Ophthalmology. All of his Internal medicine and Retrospective cohort study and Immunosuppression investigations are sub-components of the entire Internal medicine study.

In his research, Scleritis and Granulomatosis with polyangiitis is intimately related to Rheumatoid arthritis, which falls under the overarching field of Incidence. Douglas A. Jabs has included themes like Severity of illness and Acquired immunodeficiency syndrome in his Prospective cohort study study. Douglas A. Jabs interconnects Lesion, Retinitis, Cytomegalovirus retinitis, Immunodeficiency and Cross-sectional study in the investigation of issues within Acquired immunodeficiency syndrome.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.

Douglas A Jabs;Robert B Nussenblatt;James T Rosenbaum.
American Journal of Ophthalmology (2005)

4449 Citations

Paraneoplastic Pemphigus: An Autoimmune Mucocutaneous Disease Associated with Neoplasia

GJ Anhalt;SC Kim;JR Stanley;NJ Korman.
The New England Journal of Medicine (1990)

1246 Citations

Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel

Douglas A. Jabs;James T. Rosenbaum;C.Stephen Foster;Gary N. Holland.
American Journal of Ophthalmology (2000)

1036 Citations

Guidelines for preventing opportunistic infections among HIV-infected persons - 2002

Henry Masur;Jonathan E. Kaplan;King K. Holmes;Beverly Alston.
Annals of Internal Medicine (2002)

688 Citations

Thalidomide for the treatment of chronic graft-versus-host disease.

G B Vogelsang;E R Farmer;A D Hess;V Altamonte.
The New England Journal of Medicine (1992)

515 Citations

Cytomegalovirus retinitis and acquired immunodeficiency syndrome.

Douglas A. Jabs;Cheryl Enger;John G. Bartlett.
Archives of Ophthalmology (1989)

514 Citations

Gut Epithelial Barrier Dysfunction and Innate Immune Activation Predict Mortality in Treated HIV Infection

Peter W. Hunt;Elizabeth Sinclair;Benigno Rodriguez;Carey Shive.
The Journal of Infectious Diseases (2014)

470 Citations

Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders.

Grace Levy-Clarke;Douglas A. Jabs;Russell W. Read;James T. Rosenbaum.
Ophthalmology (2014)

441 Citations

Ocular Involvement in Chronic Sarcoidosis

Douglas A. Jabs;Carol J. Johns.
American Journal of Ophthalmology (1986)

414 Citations

Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease.

Justine R. Smith;Ralph D. Levinson;Gary N. Holland;Douglas A. Jabs.
Arthritis & Rheumatism (2001)

407 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Douglas A. Jabs

Susan Lightman

Susan Lightman

Moorfields Eye Hospital NHS Foundation Trust

Publications: 128

C. Stephen Foster

C. Stephen Foster

Harvard University

Publications: 128

Andrew D. Dick

Andrew D. Dick

University of Bristol

Publications: 111

Gary N. Holland

Gary N. Holland

University of California, Los Angeles

Publications: 106

James T. Rosenbaum

James T. Rosenbaum

Oregon Health & Science University

Publications: 102

William R. Freeman

William R. Freeman

University of California, San Diego

Publications: 96

Takashi Hashimoto

Takashi Hashimoto

Osaka Metropolitan University

Publications: 90

Robert B. Nussenblatt

Robert B. Nussenblatt

National Institutes of Health

Publications: 85

Jennifer E. Thorne

Jennifer E. Thorne

Johns Hopkins University

Publications: 69

Narsing A. Rao

Narsing A. Rao

University of Southern California

Publications: 55

Peter W. Hunt

Peter W. Hunt

University of California, San Francisco

Publications: 39

Aize Kijlstra

Aize Kijlstra

Maastricht University

Publications: 39

Masayuki Amagai

Masayuki Amagai

Keio University

Publications: 36

Glenn J. Jaffe

Glenn J. Jaffe

Duke University

Publications: 36

Detlef Zillikens

Detlef Zillikens

University of Lübeck

Publications: 34

Mark A. Jacobson

Mark A. Jacobson

University of California, San Francisco

Publications: 33

Trending Scientists

Piet Demeester

Piet Demeester

Ghent University

Dar-Shyang Lee

Dar-Shyang Lee

Google (United States)

Ulrich Schwaneberg

Ulrich Schwaneberg

RWTH Aachen University

Jih Ru Hwu

Jih Ru Hwu

National Tsing Hua University

Jie-Yu Wang

Jie-Yu Wang

Peking University

Takafumi Ueno

Takafumi Ueno

Tokyo Institute of Technology

Yan-Qing Li

Yan-Qing Li

East China Normal University

Eric N. Ponnampalam

Eric N. Ponnampalam

University of Melbourne

Robert W. Colman

Robert W. Colman

Temple University

Richard J. Cole

Richard J. Cole

Agricultural Research Service

Howard C. Crawford

Howard C. Crawford

University of Michigan–Ann Arbor

Sven-Erik Dahlén

Sven-Erik Dahlén

Karolinska Institute

R. Scott McClelland

R. Scott McClelland

University of Washington

Daniel E. Giammar

Daniel E. Giammar

Washington University in St. Louis

Ali Salim

Ali Salim

Brigham and Women's Hospital

Anthony S. Bryk

Anthony S. Bryk

University of Chicago

Something went wrong. Please try again later.